Literature DB >> 18481335

The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database.

Shu-Ching Hsieh1, Jung-Nien Lai, Chuan-Fang Lee, Fu-Chang Hu, Wei-Lum Tseng, Jung-Der Wang.   

Abstract

PURPOSE: The consumption of Chinese herbal products (CHPs) is increasing exponentially. However, the scientific evidence is lacking and there is an urgent requirement for detailed pharmacoepidemiological information on CHP usage. This study was to investigate CHP prescription patterns in Taiwan.
METHODS: We carried out a cross-sectional analysis on a cohort of 200,000 patients based on 2004 data from the National Health Insurance (NHI) reimbursement database. Data mining techniques were applied to explore CHP co-prescription patterns.
RESULTS: A total of 46,938 patients had been prescribed CHPs on at least one occasion in 2004. Patients using CHPs were generally female and middle-aged, made more outpatient visits, had fewer hospitalizations and consumed more medical resources than non-users of CHPs. A total of 1,073,030 CHPs were contained within 220,123 prescriptions, for which acute nasopharyngitis was the most common indication. Yan hu suo and Jia Wei Xiao Yao San were the most frequently prescribed single herb (SH) and herbal formula (HF), respectively. The results of the data mining showed that the best predictions were provided by co-prescriptions of 'Mo yao and Ru xiang', 'Ye jiao teng and Suan Zao Ren Tan' and 'Dang Gui Nian Tong Tang and Shu Jing Huo Xue Tang' in the groups of SH-SH, SH-HF and HF-HF, respectively.
CONCLUSIONS: This study provides national-level CHP prescription profiles and utilization rates, and documents, for the first time, HF-HF prescription combinations in Chinese medicine (CM) practices in Taiwan. We conclude that more studies are needed to validate the safety and effectiveness of CHP prescriptions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481335     DOI: 10.1002/pds.1611

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  33 in total

1.  Concurrent use of antiplatelets, anticoagulants, or digoxin with Chinese medications: a population-based cohort study.

Authors:  Hsin-Hui Tsai; Hsiang-Wen Lin; Chun-Ru Chien; Tsai-Chung Li
Journal:  Eur J Clin Pharmacol       Date:  2012-08-09       Impact factor: 2.953

2.  Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.

Authors:  Ming-Nan Lai; Shuo-Meng Wang; Pau-Chung Chen; Ya-Yin Chen; Jung-Der Wang
Journal:  J Natl Cancer Inst       Date:  2009-12-21       Impact factor: 13.506

3.  The traditional chinese medicine prescription pattern of endometriosis patients in taiwan: a population-based study.

Authors:  Ruei-Chi Fang; Yueh-Ting Tsai; Jung-Nien Lai; Chia-Hao Yeh; Chien-Tung Wu
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-26       Impact factor: 2.629

4.  Epigenetics in traditional chinese pharmacy: a bioinformatic study at pharmacopoeia scale.

Authors:  Hsin-Ying Hsieh; Pei-Hsun Chiu; Sun-Chong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-08       Impact factor: 2.629

5.  Increased risk for invasive breast cancer associated with hormonal therapy: a nation-wide random sample of 65,723 women followed from 1997 to 2008.

Authors:  Jung-Nien Lai; Chien-Tung Wu; Pau-Chung Chen; Chiun-Sheng Huang; Song-Nan Chow; Jung-Der Wang
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

6.  Prescriptions of traditional Chinese medicine are specific to cancer types and adjustable to temperature changes.

Authors:  Pei-Hsun Chiu; Hsin-Ying Hsieh; Sun-Chong Wang
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

7.  Evaluation of chinese-herbal-medicine-induced herb-drug interactions: focusing on organic anion transporter 1.

Authors:  Chang-Ching Lin; Hsien-Yuan Fan; Chien-Wen Kuo; Li-Heng Pao
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

8.  Prescription patterns of chinese herbal products for osteoporosis in taiwan: a population-based study.

Authors:  Wei-Tai Shih; Yao-Hsu Yang; Pau-Chung Chen
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-10       Impact factor: 2.629

Review 9.  A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicines.

Authors:  Hsin-Hui Tsai; Hsiang-Wen Lin; Ying-Hung Lu; Yi-Ling Chen; Gail B Mahady
Journal:  PLoS One       Date:  2013-05-09       Impact factor: 3.240

10.  Use of chinese medicine and subsequent surgery in women with uterine fibroid: a retrospective cohort study.

Authors:  Shan-Yu Su; Chih-Hsin Muo; Donald E Morisky
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-16       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.